62 Million Yellow Fever Vaccinations in Africa

In 2023, the global Eliminate Yellow Fever Epidemics (EYE) secretariat led by the World Health Organization (WHO) coordinated preventive and responsive vaccination efforts.

As a result, about 62 million people in Africa received yellow fever vaccinations through EYE campaigns.

According to the WHO's Disease Outbreak News on March 20, 2024, a single yellow fever vaccination can provide lifelong protection and sustained immunity for around 90% of vaccinated individuals.

The WHO says yellow fever is an acute viral hemorrhagic disease. Cases can be difficult to distinguish from other viral hemorrhagic fevers such as arenavirus, hantavirus, or dengue. Related symptoms of yellow fever usually appear 3 to 6 days after the bite of an infected mosquito.

To notify international travelers, the U.S. Centers for Disease Control and Prevention advises against yellow fever vaccination when visiting countries with a low risk of virus exposure.

For Americans seeking protection from this mosquito-transmitted disease, the YF-VAX® vaccine is available at certified travel vaccine clinics and pharmacies in the U.S.

The CDC recently reported no locally acquired yellow fever cases in 2024.